Generic name |
tadalafil |
---|---|
Strength |
20 mg |
Form | tablet |
Special Authority criteria |
Approval period |
---|---|
As monotherapy for the treatment of World Health Organization (WHO)/New York Heart Association (NYHA) functional class III or IV pulmonary arterial hypertension (PAH).
|
1 year |